{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:38:28Z","timestamp":1787315908556,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s11916-013-0358-3","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T04:31:01Z","timestamp":1375245061000},"source":"Crossref","is-referenced-by-count":58,"title":["Fibromyalgia Comorbid with Anxiety Disorders and Depression: Combined Medical and Psychological Treatment"],"prefix":"10.1007","volume":"17","author":[{"given":"Marcio","family":"Bernik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago P. A.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Gandarela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"358_CR1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2004.10.010","volume":"113","author":"B Houdenhove Van","year":"2005","unstructured":"Van Houdenhove B, Luyten P. Beyond dualism: the role of life stress in chronic pain. Pain. 2005;113:238\u20139.","journal-title":"Pain"},{"key":"358_CR2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","volume":"46","author":"RH Gracely","year":"2002","unstructured":"Gracely RH, Petzke F, Wolf JM, et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46:1333\u201343.","journal-title":"Arthritis Rheum"},{"key":"358_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10608-011-9390-y","volume":"36","author":"NA Hamilton","year":"2012","unstructured":"Hamilton NA, Atchley RA, Karlson CW, et al. The role of sleep and attention in the etiology and maintenance of fibromyalgia. Cogn Ther Res. 2012;36:81\u201393.","journal-title":"Cogn Ther Res"},{"key":"358_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000078843","volume":"73","author":"B Houdenhove Van","year":"2004","unstructured":"Van Houdenhove B, Egle UT. Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together. Psychoter Psychosom. 2004;73:267\u201375.","journal-title":"Psychoter Psychosom"},{"key":"358_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000337349","volume":"81","author":"A Konnopka","year":"2012","unstructured":"Konnopka A, Schaefert R, Heinrich S, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012;81:265\u201375.","journal-title":"Psychother Psychosom"},{"key":"358_CR6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.psym.2012.07.007","volume":"54","author":"NL Andersen","year":"2013","unstructured":"Andersen NL, Eplov LF, Andersen JT, et al. Health care use by patients with somatoform disorders: a register-based follow-up study. Psychosomatics. 2013;54:132\u201341.","journal-title":"Psychosomatics"},{"key":"358_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/CEOR.S41111","volume":"5","author":"T Knight","year":"2013","unstructured":"Knight T, Schaefer C, Chandran A, et al. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171\u201380.","journal-title":"Clinicoecon Outcomes Res"},{"key":"358_CR8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/PSY.0b013e31827264aa","volume":"74","author":"JW Warren","year":"2012","unstructured":"Warren JW, Clauw DJ. Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis. Psychosom Med. 2012;74:891\u20135.","journal-title":"Psychosom Med"},{"key":"358_CR9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600\u201310.","journal-title":"Arthritis Care Res"},{"key":"358_CR10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","volume":"65","author":"A Vincent","year":"2013","unstructured":"Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res. 2013;65:786\u201392.","journal-title":"Arthritis Care Res"},{"key":"358_CR11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","volume":"67","author":"LM Arnold","year":"2006","unstructured":"Arnold LM, Hudson JI, Keck PE, et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67:1219\u201325.","journal-title":"J Clin Psychiatry"},{"key":"358_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006842-200201000-00008","volume":"64","author":"C Dickens","year":"2002","unstructured":"Dickens C, McGowan L, Clark-Carter D, et al. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med. 2002;64:52\u201360.","journal-title":"Psychosom Med"},{"key":"358_CR13","first-page":"S79","volume":"29","author":"MG Haviland","year":"2011","unstructured":"Haviland MG, Banta JE, Przekop P. Fibromyalgia: prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999\u20132007. Clin Exp Rheumatol. 2011;29:S79\u201387.","journal-title":"Clin Exp Rheumatol"},{"key":"358_CR14","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/art.11272","volume":"48","author":"T Giesecke","year":"2003","unstructured":"Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48:2916\u201322.","journal-title":"Arthritis Rheum"},{"key":"358_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.60.1.39","volume":"60","author":"MM Ohayon","year":"2003","unstructured":"Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60:39\u201347.","journal-title":"Arch Gen Psychiatry"},{"key":"358_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000029163","volume":"33","author":"E Corruble","year":"2000","unstructured":"Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology. 2000;33:307\u20139.","journal-title":"Psychopathology"},{"key":"358_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02238767","volume":"16","author":"K Fassbender","year":"1997","unstructured":"Fassbender K, Samborsky W, Kellner M, et al. Tender points, depressive and functional symptoms: comparison between fibromyalgia and major depression. Clin Rheumatol. 1997;16:76\u20139.","journal-title":"Clin Rheumatol"},{"key":"358_CR18","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.0098-07.2007","volume":"27","author":"A Kuchinad","year":"2007","unstructured":"Kuchinad A, Schweinhardt P, Seminowicz DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of brain? J Neurosci. 2007;27:4004\u20137.","journal-title":"J Neurosci"},{"key":"358_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-3223(02)01359-8","volume":"52","author":"G Vilarreal","year":"2002","unstructured":"Vilarreal G, Hamilton DA, Petropoulos H, et al. Reduced hippocampal volume and total white matter in post-traumatic stress disorder. Biol Psychiatry. 2002;52:119\u201325.","journal-title":"Biol Psychiatry"},{"key":"358_CR20","doi-asserted-by":"crossref","unstructured":"Hsu MC, Harris RE, Sundgren PC, et al. No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain. 2009;143:262\u20137.","DOI":"10.1016\/j.pain.2009.03.017"},{"key":"358_CR21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/art.21008","volume":"52","author":"T Giesecke","year":"2005","unstructured":"Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005;52:1577\u201384.","journal-title":"Arthritis Rheum"},{"key":"358_CR22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/ajp.142.4.441","volume":"142","author":"JI Hudson","year":"1985","unstructured":"Hudson JI, Hudson MS, Pliner LF, et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry. 1985;142:441\u20136.","journal-title":"Am J Psychiatry"},{"key":"358_CR23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.20042","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Hudson J, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50:944\u201352.","journal-title":"Arthritis Rheum"},{"key":"358_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/14622416.8.1.67","volume":"8","author":"JN Ablin","year":"2007","unstructured":"Ablin JN, Buskila D, Sarzi-Puttini P. The genetics of fibromyalgia syndrome. Pharmacogenomics. 2007;8:67\u201374.","journal-title":"Pharmacogenomics"},{"key":"358_CR25","doi-asserted-by":"crossref","unstructured":"Robinson OJ, Overstreet C, Allen PS, et al. The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala \u201caversive amplification\u201d circuit. Neuroimage. 2013. [Epub ahead of print].","DOI":"10.1016\/j.neuroimage.2013.03.075"},{"key":"358_CR26","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.36076\/ppj.2011\/14\/E217","volume":"14","author":"HS Smith","year":"2011","unstructured":"\u2022\u2022 Smith HS, Harris R, Clauwn D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Phys. 2011;14:E217\u201345. This study provides an extensive review on the CNS pathophysiology of fibromyalgia and the mechanisms of action of drugs used in its treatment.","journal-title":"Pain Phys"},{"key":"358_CR27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5665\/sleep.2364","volume":"36","author":"V Mysliwiec","year":"2013","unstructured":"Mysliwiec V, McGraw L, Pierce R, et al. Sleep disorders and associated medical comorbidities in active duty military personnel. Sleep. 2013;36:167\u201374.","journal-title":"Sleep"},{"key":"358_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000539-200207000-00029","volume":"95","author":"F Yokogawa","year":"2002","unstructured":"Yokogawa F, Kiuchi Y, Ishikawa Y, et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg. 2002;95:163\u20138.","journal-title":"Anesth Analg"},{"key":"358_CR29","first-page":"469","volume":"20","author":"EN Griep","year":"1993","unstructured":"Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 1993;20:469\u201374.","journal-title":"J Rheumatol"},{"issue":"Supl I","key":"358_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1590\/S1516-44462003000500006","volume":"25","author":"FG Graeff","year":"2003","unstructured":"Graeff FG. Bases biol\u00f3gicas do transtorno de estresse p\u00f3s-traum\u00e1tico. Rev Bras Psiquiatr. 2003;25(Supl I):21\u20134.","journal-title":"Rev Bras Psiquiatr"},{"key":"358_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/15299732.2012.736930","volume":"14","author":"D Bohn","year":"2013","unstructured":"Bohn D, Bernardy K, Wolfe F, et al. The association among child maltreatment, somatic symptoms intensity, depression, and somatoform dissociative symptoms in patients with fibromyalgia syndrome? A single-center cohort study. J Trauma Dissociation. 2013;14:342\u201358.","journal-title":"J Trauma Dissociation"},{"key":"358_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejim.2011.11.016","volume":"23","author":"D Lucini","year":"2012","unstructured":"Lucini D, Pagani M. From stress to functional syndromes: an internist\u2019s point of view. Eur J Intern Med. 2012;23:295\u2013301.","journal-title":"Eur J Intern Med"},{"key":"358_CR33","doi-asserted-by":"crossref","unstructured":"Gonzalez B, Baptista TM, Branco JC, et al. Fibromyalgia: antecedent life events, disability, and causal attribution. Psychol Health Med. 2013. [Epub ahead of print].","DOI":"10.1080\/13548506.2012.752098"},{"issue":"1421\u20132","key":"358_CR34","first-page":"1424","volume":"7","author":"E Masquelier","year":"2011","unstructured":"Masquelier E, Scaillet N, Luminet O, et al. What\u2019s about overactive lifestyle in fibromyalgia and chronic fatigue syndrome. Rev Med Suisse. 2011;7(1421\u20132):1424\u20135.","journal-title":"Rev Med Suisse"},{"key":"358_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/ar2967","volume":"12","author":"KR Fontaine","year":"2010","unstructured":"Fontaine KR, Conn L, Clauw DJ. Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Res Ther. 2010;12:55. Available at: http:\/\/arthritis-research.com\/content\/12\/2\/R55 . Accessed May 2013.","journal-title":"Arthritis Res Ther"},{"issue":"6 Suppl 69","key":"358_CR36","first-page":"S70","volume":"29","author":"R Alok","year":"2011","unstructured":"Alok R, Das SK, Agarwal GG, et al. Relationship of severity of depression, anxiety and stress with severity of fibromyalgia. Clin Exp Rheumatol. 2011;29(6 Suppl 69):S70\u20132.","journal-title":"Clin Exp Rheumatol"},{"key":"358_CR37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1348\/000711299160185","volume":"72","author":"N Kurtze","year":"1999","unstructured":"Kurtze N, Gundersen KT, Svebak S. Quality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: the significance of anxiety and depression. Br J Med Psychol. 1999;72:471\u201384.","journal-title":"Br J Med Psychol"},{"key":"358_CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4081\/reumatismo.2012.275","volume":"64","author":"K Thieme","year":"2012","unstructured":"Thieme K, Turk DC. Cognitive-behavioural and operant-behavioral therapy for people with fibromyalgia. Reumatismo. 2012;64:275\u201385.","journal-title":"Reumatismo"},{"key":"358_CR39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/art.21158","volume":"53","author":"K Thieme","year":"2005","unstructured":"Thieme K, Spies C, Sinha P, et al. Predictors of pain behaviors in fibromyalgia syndrome. Arthritis Rheum. 2005;53:343\u201350.","journal-title":"Arthritis Rheum"},{"key":"358_CR40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10705500802222964","volume":"15","author":"S Koulil Van","year":"2008","unstructured":"Van Koulil S, Kraaimaat FW, van Lankeveld W, et al. Screening for pain-persistence and pain-avoidance patterns in fibromyalgia. Intern J Behav Med. 2008;15:211\u201320.","journal-title":"Intern J Behav Med"},{"key":"358_CR41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.20445","volume":"63","author":"S Koulil Van","year":"2011","unstructured":"Van Koulil S, Kraaimaat FW, van Lankeveld W, et al. Cognitive-behavioral mechanisms in a pain-avoidance and a pain-persistence treatment for high-risk fibromyalgia patients. Arthritis Care Res. 2011;63:800\u20137.","journal-title":"Arthritis Care Res"},{"key":"358_CR42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1176\/appi.psy.49.6.470","volume":"49","author":"B Houdenhove Van","year":"2008","unstructured":"Van Houdenhove B, Luyten P. Customizing treatment of chronic fatigue syndrome and fibromyalgia: the role of perpetuating factors. Psychosomatics. 2008;49:470\u20137.","journal-title":"Psychosomatics"},{"key":"358_CR43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1017\/S109285290001436X","volume":"11","author":"P Salmon","year":"2006","unstructured":"Salmon P. The potentially somatizing effect of clinical consultation. CNS Spectr. 2006;11:190\u2013200.","journal-title":"CNS Spectr"},{"key":"358_CR44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejpain.2009.01.006","volume":"14","author":"W H\u00e4user","year":"2010","unstructured":"\u2022 H\u00e4user W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome \u2013a systematic review. Eur J Pain. 2010;14:5\u201310. There are many different guidelines for the treatment of fibromyalgia. In this study, the authors compare 3 important guidelines, highlighting similarities and differences in their recommendations.","journal-title":"Eur J Pain"},{"key":"358_CR45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1533-2500.2012.00578.x","volume":"13","author":"JV Pergolizzi Jr","year":"2013","unstructured":"Pergolizzi Jr JV, Raffa RB, Taylor Jr R, et al. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract. 2013;13:239\u201352.","journal-title":"Pain Pract"},{"key":"358_CR46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AJP.0b013e3182510295","volume":"28","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Zhang S, Pangallo BA. Efficacy and safety of duloxetine 30 mg\/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. Clin J Pain. 2012;28:775\u201381.","journal-title":"Clin J Pain"},{"key":"358_CR47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1526-4637.2009.00755.x","volume":"11","author":"DL Goldenberg","year":"2010","unstructured":"Goldenberg DL, Clauwn DJ, Palmer RH, et al. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study. Pain Med. 2010;11:180\u201394.","journal-title":"Pain Med"},{"key":"358_CR48","first-page":"CD006529","volume":"3","author":"A Nakagawa","year":"2009","unstructured":"Nakagawa A, Watanabe N, Omori IM, et al. Milnacipran vs other antidepressive agents for depression. Cochrane Database Syst Rev. 2009;3:CD006529. doi: 10.1002\/14651858.CD006529.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"key":"358_CR49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","volume":"301","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, U\u00e7eyler N, et al. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009;301:198\u20132009.","journal-title":"JAMA"},{"key":"358_CR50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1345\/aph.1Q405","volume":"46","author":"TM Wensel","year":"2012","unstructured":"Wensel TM, Powe KW, Cates ME. Pregabalin for the treatment of generalized anxiety disorder. Ann Pharmacother. 2012;46:424\u20139.","journal-title":"Ann Pharmacother"},{"key":"358_CR51","first-page":"CD010292","volume":"1","author":"W H\u00e4user","year":"2013","unstructured":"H\u00e4user W, Urr\u00fatia G, Tort S, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database of Syst Rev. 2013;1:CD010292. doi: 10.1002\/14651858.CD010292 .","journal-title":"Cochrane Database of Syst Rev"},{"key":"358_CR52","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clinthera.2010.08.003","volume":"32","author":"LM Arnold","year":"2010","unstructured":"Arnold LM, Chatamra K, Hirsch I, et al. Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2010;32:1618\u201332.","journal-title":"Clin Ther"},{"key":"358_CR53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/JCP.0b013e31824858dc","volume":"32","author":"EN Mariutto","year":"2012","unstructured":"Mariutto EN, Stanford SB, Kashikar-Zuck S, et al. An exploratory, open trial of fluoxetine treatment of juvenile fibromyalgia. J Clin Psychopharmacol. 2012;32:293\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"358_CR54","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hup.1256","volume":"26","author":"DJ Stein","year":"2011","unstructured":"Stein DJ, Bandelow B, Merideth C, et al. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder: an analysis of pooled data from 3 8-week placebo-controlled studies. Hum Psychopharmacol. 2011;26:614\u201328.","journal-title":"Hum Psychopharmacol"},{"key":"358_CR55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2006.06.023","volume":"31","author":"J Hidalgo","year":"2007","unstructured":"Hidalgo J, Rico-Villademoros F, Calandre EP. An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:71\u20137.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"358_CR56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","volume":"32","author":"S Potvin","year":"2012","unstructured":"Potvin S, Morin M, Cloutier C, et al. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial. J Clin Psychopharmacol. 2012;32:684\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"358_CR57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/JCP.0b013e318184ff5b","volume":"28","author":"DJ Stein","year":"2008","unstructured":"Stein DJ, Ahokas AA, de Bodinat C. Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2008;28:561\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"358_CR58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.psc.2012.03.006","volume":"35","author":"K Miotto","year":"2012","unstructured":"Miotto K, Kaufman A, Kong A, et al. Managing co-occurring substance use and pain disorders. Psychiatr Clin North Am. 2012;35:393\u2013409.","journal-title":"Psychiatr Clin North Am"},{"key":"358_CR59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/RHU.0b013e3182863447","volume":"19","author":"JT Painter","year":"2013","unstructured":"\u2022 Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol. 2013;19:72\u20137. This study warns for the increases in chronic daily opioid use in fibromyalgia and the risks it poses to aggravating the deficient pain suppression mechanism found in these patients.","journal-title":"J Clin Rheumatol"},{"key":"358_CR60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archpsyc.1979.01780050065007","volume":"36","author":"T Wehr","year":"1979","unstructured":"Wehr T, Goodwin F. Rapid cycling in manic depression induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979;36:555\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"358_CR61","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1192\/bjp.bp.112.120550","volume":"202","author":"ME Thase","year":"2013","unstructured":"Thase ME. Antidepressants and rapid-cycling bipolar II disorder: dogma, definitions and deconstructing discrepant data. BJP. 2013;202:251\u20132.","journal-title":"BJP"},{"key":"358_CR62","doi-asserted-by":"crossref","unstructured":"Gahr M, Freudenmann RW, Hiemke C, et al. Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol. 2013. [Epub ahead of print].","DOI":"10.1007\/s00228-012-1464-6"},{"key":"358_CR63","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.rdc.2008.03.007","volume":"34","author":"E Ernst","year":"2008","unstructured":"Ernst E. Complementary treatments in rheumatic diseases. Rheum Dis Clin North Am. 2008;34:455\u201367.","journal-title":"Rheum Dis Clin North Am"},{"key":"358_CR64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/ahe.12.45","volume":"8","author":"R Yachoui","year":"2012","unstructured":"Yachoui R, Kolasinski SL. Complementary and alternative medicine for rheumatic diseases. Aging Health. 2012;8:403\u201312.","journal-title":"Aging Health"},{"key":"358_CR65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10067-011-1783-5","volume":"31","author":"R Terry","year":"2012","unstructured":"Terry R, Perry R, Ernst E. An overview of systematic reviews of complementary and alternative medicine for fibromyalgia. Clin Rheumatol. 2012;31:55\u201366.","journal-title":"Clin Rheumatol"},{"key":"358_CR66","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/kep439","volume":"49","author":"J Laghorst","year":"2010","unstructured":"Laghorst J, Klose P, Musial F, et al. Efficacy of acupuncture in fibromyalgia syndrome \u2013a systematic review with a meta analysis of controlled clinical trials. Rheumatology. 2010;49:778\u201388.","journal-title":"Rheumatology"},{"key":"358_CR67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-143-1-200507050-00005","volume":"143","author":"NP Assefi","year":"2005","unstructured":"Assefi NP, Sherman KJ, Jacobsen C, et al. A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med. 2005;143:10\u20139.","journal-title":"Ann Intern Med"},{"key":"358_CR68","volume-title":"An overview of complementary and alternative medicine therapies for anxiety and depressive disorders: supplement to efficacy of complementary and alternative medicine therapies for posttraumatic stress disorder","author":"JW Williams Jr","year":"2011","unstructured":"Williams Jr JW, Gierisch JM, McDuffie J, et al. An overview of complementary and alternative medicine therapies for anxiety and depressive disorders: supplement to efficacy of complementary and alternative medicine therapies for posttraumatic stress disorder. Washington (DC): Department of Veterans Affairs; 2011. Available at http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK82787 . Accessed May 2013."},{"key":"358_CR69","first-page":"141","volume":"18","author":"MP Delgado","year":"2012","unstructured":"Delgado MP, Postigo JML, Rodr\u00edguez JM. Terapia cognitiva basada en mindfulness y reducci\u00f3n de los s\u00edntomas de ansiedad en personas con fibromialgia. Ansiedad y Estr\u00e9s. 2012;18:141\u201354.","journal-title":"Ansiedad y Estr\u00e9s"},{"key":"358_CR70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.comppsych.2009.01.008","volume":"50","author":"S V\u00e1zquez-Rivera","year":"2009","unstructured":"V\u00e1zquez-Rivera S, Gonz\u00e1lez-Blanch C, Rodr\u00edguez-Moya L, et al. Brief cognitive-behavioral therapy with fibromyalgia patients in routine care. Compr Psychiatry. 2009;50:517\u201325.","journal-title":"Compr Psychiatry"},{"key":"358_CR71","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pain.2010.06.011","volume":"151","author":"JA Glombiewski","year":"2010","unstructured":"\u2022 Glombiewski JA, Sawyer AT, Gutermann J, et al. Psychological treatments for fibromyalgia: a meta-analysis. Pain. 2010;151:280\u201395. An important systematic review and meta-analysis on psychological treatments for fibromyalgia, concluding on the efficacy of structured cognitivecbehavioral psychotherapy.","journal-title":"Pain"},{"key":"358_CR72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/JPR.S35199","volume":"5","author":"F Friedberg","year":"2012","unstructured":"Friedberg F, Williams DA, Collinge W. Lifestyle-oriented non-pharmacological treatments for fibromyalgia: a clinical overview and applications with home-based technologies. J Pain Res. 2012;5:425\u201335.","journal-title":"J Pain Res"},{"key":"358_CR73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10608-012-9476-1","volume":"36","author":"SG Hofmann","year":"2012","unstructured":"Hofmann SG, Asnaani A, Vonk IJJ, et al. The efficacy of cognitive behavioral therapy: a review of meta-analysis. Cognit Ther Res. 2012;36:427\u201340.","journal-title":"Cognit Ther Res"},{"key":"358_CR74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1479-8425.2010.00481.x","volume":"9","author":"I Okajima","year":"2011","unstructured":"Okajima I, Komada Y, Inoue Y. A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms. 2011;9:24\u201334.","journal-title":"Sleep Biol Rhythms"},{"key":"358_CR75","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jpain.2012.12.019","volume":"14","author":"S Kashikar-Zuck","year":"2013","unstructured":"Kashikar-Zuck S, Sil S, Lynch-Jordan AM, et al. Changes in pain coping, catastrophizing, and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia. J Pain. 2013;14:492\u2013501.","journal-title":"J Pain"},{"key":"358_CR76","first-page":"2257","volume":"30","author":"JA Astin","year":"2003","unstructured":"Astin JA, Berman BM, Bausell B, et al. The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial. J Rheumatol. 2003;30:2257\u201362.","journal-title":"J Rheumatol"},{"key":"358_CR77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000101501","volume":"76","author":"P Grossman","year":"2007","unstructured":"Grossman P, Tiefenthaler-Gilmer U, Raysz A, et al. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007;76:226\u201333.","journal-title":"Psychother Psychosom"},{"key":"358_CR78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pain.2010.10.043","volume":"152","author":"S Schmidt","year":"2011","unstructured":"Schmidt S, Grossman P, Schwarzer B, et al. Treating fibromyalgia with mindfulness-based stress reduction: results from a 3-armed randomized controlled trial. Pain. 2011;152:361\u20139.","journal-title":"Pain"},{"key":"358_CR79","first-page":"B4547","volume":"59","author":"LO Fjorback","year":"2012","unstructured":"Fjorback LO. Mindfulness and bodily distress. Dan Med J. 2012;59:B4547.","journal-title":"Dan Med J"},{"key":"358_CR80","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/j.1532-2149.2012.00224.x","volume":"17","author":"RK Wicksell","year":"2013","unstructured":"Wicksell RK, Kemani M, Jensen K, et al. Acceptance and commitment therapy for fibromyalgia: a randomized controlled trial. Eur J Pain. 2013;17:599\u2013611.","journal-title":"Eur J Pain"},{"key":"358_CR81","doi-asserted-by":"crossref","unstructured":"Ang DC, Jensen MP, Steiner JL, et al. Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial. Clin J Pain. 2013. [Epub ahead of print].","DOI":"10.1097\/AJP.0b013e31827a784e"},{"key":"358_CR82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cyber.2012.1572","volume":"16","author":"C Botella","year":"2013","unstructured":"Botella C, Garcia-Palacios A, Vizca\u00edno Y, et al. Virtual reality in the treatment of fibromyalgia: a pilot study. Cyber Psychol Behav Soc Netw. 2013;16:215\u201323.","journal-title":"Cyber Psychol Behav Soc Netw"},{"key":"358_CR83","volume-title":"Acceptance and commitment therapy: an experiential approach to behavior change","author":"SC Hayes","year":"1999","unstructured":"Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: an experiential approach to behavior change. New York-London: The Guilford Press; 1999."},{"key":"358_CR84","doi-asserted-by":"crossref","unstructured":"Kaleth AS, Saha CK, Jensen MP, et al. Moderate-vigorous physical activity improves long-term clinical outcomes without worsening pain in fibromyalgia. Arthritis Care Res. 2013 [Epub ahead of print].","DOI":"10.1002\/acr.21980"},{"key":"358_CR85","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/ar3159","volume":"12","author":"K Mannerkorpi","year":"2010","unstructured":"Mannerkorpi K, Nordeman L, Cider A, et al. Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Res Ther. 2010;12:R189.","journal-title":"Arthritis Res Ther"},{"key":"358_CR86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpain.2011.11.001","volume":"13","author":"LD Ellingson","year":"2012","unstructured":"Ellingson LD, Shields MR, Stegner AJ, et al. Physical activity, sustained sedentary behavior, and pain modulation in women with fibromyalgia. J Pain. 2012;13:195\u2013206.","journal-title":"J Pain"},{"key":"358_CR87","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jpain.2010.12.004","volume":"12","author":"MJ McLoughlin","year":"2011","unstructured":"McLoughlin MJ, Stegner AJ, Cook DB. The relationship between physical activity and brain responses to pain in fibromyalgia. J Pain. 2011;12:640\u201351.","journal-title":"J Pain"},{"key":"358_CR88","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar4200","volume":"15","author":"CH Kim","year":"2013","unstructured":"Kim CH, Vincent A, Clauw DJ, et al. Association between alcohol consumption and symptom severity and quality of life in patients with fibromyalgia. Arthritis Res Ther. 2013;15:R42.","journal-title":"Arthritis Res Ther"},{"key":"358_CR89","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0032-1305096","volume":"39","author":"M Freidl","year":"2012","unstructured":"Freidl M, Piralic-Spitzl S, Grohe N, et al. Association between fear of stigma, depressive and anxiety symptoms in patients with somatoform pain disorder. Psychiatr Prax. 2012;39:263\u20136.","journal-title":"Psychiatr Prax"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-013-0358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-013-0358-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-013-0358-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:36:14Z","timestamp":1646220974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-013-0358-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1007\/s11916-013-0358-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]},"article-number":"358"}}